H. Lundbeck AS - Company Profile
Powered by 
All the sales intelligence you need on H. Lundbeck AS in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how H. Lundbeck AS fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with H. Lundbeck AS.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on H. Lundbeck AS’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 08 Jun 2023 | H. Lundbeck AS Enters Phase III Clinical Trial Agreement with PPD Inc for eptinezumab (GDCT0490272) | Contract Service Agreement |
H. Lundbeck AS
|
PPD Inc |
| 08 May 2023 | Neuro3 Therapeutics Enters into Licensing Agreement with Lundbeck | Licensing Agreement |
Neuro3 Therapeutics Inc
|
H. Lundbeck AS |
| 02 May 2023 | Alloy Therapeutics Enters into Agreement with H Lundbeck | Partnership | - |
H. Lundbeck AS
Alloy Therapeutics LLC
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer